v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Income Statement Information

The following table provides selected income statement information for our single reportable segment (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net loss before noncontrolling interest

$

(46,436

)

 

$

(36,965

)

 

$

(89,057

)

 

$

(74,917

)

Rental income

 

150

 

 

 

221

 

 

 

376

 

 

 

451

 

Depreciation and amortization

 

1,449

 

 

 

1,491

 

 

 

2,883

 

 

 

2,875

 

Equity-based compensation

 

5,594

 

 

 

6,540

 

 

 

10,539

 

 

 

12,957

 

Income tax expense

 

–

 

 

 

848

 

 

 

–

 

 

 

1,439

 

Interest expense

 

(1

)

 

 

(1

)

 

 

(16

)

 

 

(1

)

Interest income

 

1,938

 

 

 

3,593

 

 

 

4,265

 

 

 

7,620

 
Schedule of Significant Expense Reported to the Chief Operating Decision Maker

The following table provides significant expense categories that are regularly reported to the CODM (in thousands):

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

$

150

 

 

$

221

 

 

$

376

 

 

$

451

 

 

 

 

 

 

 

 

 

 

 

 

 

Clinical trial expense

 

14,185

 

 

 

7,188

 

 

 

27,346

 

 

 

14,711

 

Cash compensation

 

13,316

 

 

 

13,811

 

 

 

27,545

 

 

 

27,064

 

Cash operating expenses

 

13,705

 

 

 

11,595

 

 

 

24,560

 

 

 

24,739

 

Other segment items (1)

 

5,380

 

 

 

4,592

 

 

 

9,982

 

 

 

8,854

 

Net loss before noncontrolling interest

$

(46,436

)

 

$

(36,965

)

 

$

(89,057

)

 

$

(74,917

)
(1)
Other segment items primarily include interest income, equity-based compensation and depreciation.